as 1402

Sontuzumab (AS1402)为人源IgG1κMUC1特异性单克隆抗体，其结合细胞外MUC1肽序列PDTR，亲和常数（Kd）约为1 nM。该抗体主要应用于乳腺癌的研究。

JPI 547, also known as NOV 1402, is an oral inhibitor of PARP 1 2 and Tankyrase 1 2. JPI-547 demonstrated anti-tumor activity in BRCA-deficient xenograft models as a single-agent and in combination with chemotherapy and immune checkpoint inhibitors.

Fmoc-Gly-Gly-Phe-Gly-CH2-O-CH2-Gly-CH2-O-CH2-Cbz 是ADC linker的一种，主要应用于ADC的合成，例如Trastuzumab deruxtecan 和 U3-1402。